Published on: 22 October 2021 Roche’s VENTANA PD-L1 (SP263) Assay receives FDA approval as a companion diagnostic to identify certain non-small cell lung cancer patients eligible for Tecentriq® (atezolizumab) more
Published on: 20 October 2021 [Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong growth in the first nine months – outlook for 2021 raised more
125 Years Celebrate Life Learn more about Roche’s 125 year anniversary and the Celebrate Life campaign more
